期刊文献+

共表达H5N1流感病毒M1和HA基因的DNA疫苗与腺病毒载体疫苗的小鼠免疫评价(英文) 被引量:7

Evaluation of the immune response to recombinant DNA vaccine and adenoviral vaccine co-expressing the M1 and HA genes of H5N1 influenza virus in mice
原文传递
导出
摘要 为评价在小鼠体内表达流感病毒M1和HA基因诱导的免疫反应,制备共表达H5N1亚型禽流感病毒(A/Anhui/1/2005)全长基质蛋白1(M1)基因和血凝素(HA)基因的重组DNA疫苗pStar-M1/HA和重组腺病毒载体疫苗Ad-M1/HA,将其按初免-加强程序免疫BALB/c小鼠,共免疫4次,每次间隔14 d。第1、3次用DNA疫苗,第2、4次用重组腺病毒载体疫苗,每次免疫前及末次免疫后14 d采集小鼠血清用于检测体液免疫应答,末次免疫后14 d采集小鼠脾淋巴细胞用于检测细胞免疫应答。血凝抑制(HI)实验和ELISA实验检测到免疫后小鼠血清中抗H5N1亚型流感病毒特异性IgG抗体。ELISPOT实验检测到免疫后小鼠针对M1和HA的特异性细胞免疫应答。共表达H5N1流感病毒M1和HA基因的DNA疫苗与腺病毒载体疫苗在小鼠体内的免疫学评价,为研究开发新型重组流感疫苗奠定了基础。 In order to evaluate the response to vector-expressed M1 and HA genes of influenza virus in mice,we prepared recombinant plasmid pStar-M1/HA and recombinant adenovirus Ad-M1/HA containing both the full-length matrix protein 1(M1) and hemagglutinin(HA) genes of human H5N1 influenza virus strain A/Anhui/1/2005.We then combined the DNA vaccine and adenoviral vaccine in immunization of BALB/c mice with a prime-boost regime.We immunized the mice with DNA vaccine at day 0 and 28 and with recombinant adenoviral vaccines at day 14 and 42.We took blood samples before each injection and 14 days after the final injection for detection of humoral immune responses.At day 56,we sacrificed the mice and collected splenocytes for detection of cellular immune responses.ELISA and hemagglutination inhibition(HI) assay showed that specific IgG Abs against H5N1 influenza virus was induced in serum of the immunized mice.ELISPOT results confirmed that the specific cellular immune responses were successfully induced against the M1 and HA proteins of H5N1 influenza virus.This study provides new strategy for development of novel influenza vaccines.
出处 《生物工程学报》 CAS CSCD 北大核心 2011年第6期876-883,共8页 Chinese Journal of Biotechnology
基金 国家科技重大专项(No.2009ZX10004-710)资助~~
关键词 H5N1亚型流感病毒 基质蛋白1 血凝素(HA) 共表达 联合免疫 H5N1 influenza virus matrix protein 1(M1) hemagglutinin(HA) co-expression combined immunization
  • 相关文献

参考文献22

  • 1Claas EC, Osterhaus AD, van Beek R, et al. Human influenza A H5NI virus related to a highly pathogenic avian influenza virus. Lancet, 1998, 351(9101): 472-477.
  • 2Subbarao K, Klimov A, Katz J, et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science, 1998, 279(5349): 393 396.
  • 3Yu H, Shu Y, Hu S, et al. The first confirmed human case of avian influenza A (H5NI) in China's Mainland. Lancet, 2006, 367(9504): 84.
  • 4Helenius A. Unpacking the incoming influenza virus. Cell, 1992, 69(4): 577-578.
  • 5Watanabe K, Handa H, Mizumoto K, et al. Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein. J Virol, 1996, 70(1): 241-247.
  • 6Nayak DP, Hui EKW, Barman S. Assembly and budding of influenza virus. Virus Res, 2004, 106(2): 147-165.
  • 7Holterman L, Vogels R, van der Vlugt R, et al. Novel replicationincompetent vector derived from adenovirus type 11 (Adll) for vaccination and non-cross-reactivity with Ad5. J Virol, 2004, 78(23): 13207-13215.
  • 8Gao WT, Soloff AC, Lu XH, et al. Protection of mice and poultry from lethal H5NI avian influenza virus through adenovirus-based immunization. J Virol, 2006, 80(4): 1959-1964.
  • 9Hoeslscher MA, Garg S, Bangari DS, et al. Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet, 2006, 367(9509): 475-481.
  • 10郭建强,姚立红,陈爱珺,徐一,刘晓宇,舒跃龙,张智清.甲型H5N1流感病毒M2与HA双基因载体疫苗在小鼠体内的免疫学评价[J].生物工程学报,2010,26(5):649-656. 被引量:1

二级参考文献10

  • 1Yu H, Shu Y, Hu S, et al. The first confirmed human case of avian influenza A (H5N1) in China's Mainland. Lancet, 2006, 367(9504): 84.
  • 2Holterman L, Vogels R, van der Vlugt R, et al. Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5. J PTrol, 2004, 78(23): 13207-13215.
  • 3Gao W, Soloff AC, Lu X, et al. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol, 2006, 80(4): 1959-1964.
  • 4Hoeslscher MA, Garg S, Bangari DS, et al. Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet, 2006, 367(9509): 475-481.
  • 5Fedson DS. Pandemic influenza and the global vaccine supply. Clin lnfect Dis, 2003, 36(12): 1552-1561.
  • 6Kochanek S, Schiedner G, Volpers C. High-capacity 'gutless' adenoviral vectors. Curr Opin Mol Ther, 2001, 3(5): 454-463.
  • 7Singh N, Pandey A, Jayashankar L, et al. Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus. Mol Ther, 2008, 16(5): 965-971.
  • 8Ito T, Gorman OT, Kawaoka Y, et al. Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. J Virol, 1991, 65(10): 5491-5498.
  • 9Black RA, Rota PA, Gorodkova N, et al. Antibody response to the M2 protein of influenza A virus expressed in insect cells. J Gen Virol, 1993, 4(Pt1): 143-146.
  • 10Treanor J J, Tierney EL, Zebedee SL, et al. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol, 1990, 64(3): 1375-1377.

同被引文献64

  • 1姜永萍,于康震,邓国华,田国斌,乔传玲,陈化兰.表达H5亚型禽流感病毒HA基因的DNA疫苗免疫保护效力研究[J].中国农业科学,2004,37(7):1071-1075. 被引量:11
  • 2陈清,俞守义,申洪,王雅贤,吴敏.产毒性大肠杆菌的致病机制[J].第一军医大学学报,2003,23(8):826-829. 被引量:13
  • 3金天明,武迎红.腺病毒及腺病毒载体的研究进展[J].天津农学院学报,2007,14(2):48-51. 被引量:5
  • 4Carrat F, Flahault A. Influenza vaccine: the challenge of anti- genic drift[J]. Vaccine, 2007,25 (39-40) : 6852- 6862.
  • 5Dinh D T, Le M T, Vuong C D, et al. An updated loop-media- ted isothermal amplification method for rapid diagnosis of H5N1 Avian influenza viruses[J]. Trop Med Health, 2011,39(1) :3-7.
  • 6Hankins R W, Nagata K, Kato A, et al. Mechanism of influenza virus transcription inhibition by matrix (M1) protein[J]. Res Virol, 1990,141 (3) : 305 - 314.
  • 7Normile D. Avian influenza warning of H5N1 resurgence surpri ses community. Science,2011,333(6048) :1369.
  • 8Pysina T V, Gorbunova A S. Relation between the pathogenicity of avian influenza viruses for laboratory animals and infection of avifauna[J]. Vopr Virusol, 1970,15(3) : 298-301.
  • 9Roti M, Yang J, et al. Healthy human subjects have CD^4+ T cells directed against HSN1 in{luenza virus [J]. J Immunol, 2008,180(3) : 1758- 1768.
  • 10Subbarao K, Klimov A, Katz J, et al. Characterization of an avi- an influenza A (HSN1) virus isolated from a child with a fatal re- spiratory illness[J]. Science, 1998,279 (5349) : 393- 396.

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部